Terminology Service for NFDI4Health
Gemcitabine-Carboplatin Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C63410
A regimen consisting of gemcitabine and carboplatin that can be used to treat malignant mesothelioma, and non-small cell lung, breast, ovarian, fallopian tube, primary peritoneal and kidney cancers. [ ]
Term info
Label
Gemcitabine-Carboplatin Regimen
Synonyms
- Carboplatin + Gemcitabine Regimen
- Carboplatin-Gemcitabine
- Carboplatin/Gemcitabine
- Carboplatin/Gemcitabine Regimen
- Gemcitabine-Carboplatin
- Gemcitabine-Carboplatin Regimen
- Gemcitabine/Carboplatin
Subsets
NCIT_C160952, NCIT_C160950
DesignNote
Source: NCCN Guidelines 2019
Legacy Concept Name
Gemcitabine-Carboplatin_Regimen
Preferred Name
Gemcitabine-Carboplatin Regimen
Semantic Type
Therapeutic or Preventive Procedure
UMLS CUI
C1880938
code
C63410
Term relations
Subclass of:
- Regimen Used to Treat Non-Small Cell Lung Carcinoma
- Regimen Used to Treat Breast Carcinoma
- Regimen Used to Treat Malignant Mesothelioma
- Regimen Used to Treat Malignant Ovarian Neoplasm
- Chemotherapy_Regimen_Has_Component some Carboplatin
- Chemotherapy_Regimen_Has_Component some Gemcitabine Hydrochloride
- Regimen_Has_Accepted_Use_For_Disease some Malignant Mesothelioma
- Regimen_Has_Accepted_Use_For_Disease some Ovarian Carcinoma
- Regimen_Has_Accepted_Use_For_Disease some Lung Non-Small Cell Carcinoma